Human umbilical cord mesenchymal stem cells to treat spinal cord injury in the early chronic phase: study protocol for a prospective, multicenter, randomized, placebo-controlled, single-blinded clinical trial

Human umbilical cord mesenchymal stem cells (hUC-MSCs) support revascularization, inhibition of inflammation, regulation of apoptosis, and promotion of the release of beneficial factors. Thus, they are regarded as a promising candidate for the treatment of intractable spinal cord injury (SCI). Clini...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yang, Pang, Mao, Chen, Yu-Yong, Zhang, Liang-Ming, Liu, Hao, Tan, Jun, Liu, Bin, Rong, Li-Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7059580/
https://www.ncbi.nlm.nih.gov/pubmed/31997819
http://dx.doi.org/10.4103/1673-5374.274347

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7059580/
https://www.ncbi.nlm.nih.gov/pubmed/31997819
http://dx.doi.org/10.4103/1673-5374.274347

Ejemplares similares